Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joske Hoes"'
Autor:
Tessa M. Schurink‐van ’t Klooster, Albert G. Siebers, Joske Hoes, Folkert J. vanKemenade, Johannes Berkhof, Johannes A. Bogaards, Hester E. deMelker
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11786-11794 (2023)
Abstract Background The first HPV‐vaccine eligible cohorts in the Netherlands will enter the cervical screening program in 2023. However, a substantial number of young women already have had a cervical sample taken before entry into the regular scr
Externí odkaz:
https://doaj.org/article/0493e70b23d14ab59d97e807604f0375
Autor:
Joske Hoes, Anna G. C. Boef, Mirjam J. Knol, Hester E. de Melker, Liesbeth Mollema, Fiona R. M. van der Klis, Nynke Y. Rots, Debbie van Baarle
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
Background: We investigated whether low socioeconomic status (SES), which is associated with reduced health and life expectancy, might play a role in increased risk for infectious diseases. Therefore, we explored the association between SES and immun
Externí odkaz:
https://doaj.org/article/008c368be6b64d86b8f637044117987e
Autor:
Joske Hoes, Audrey J. King, Hester E. de Melker, Johannes Berkhof, Tessa M Schurink-van 't Klooster, Johannes A. Bogaards
Publikováno v:
Journal of Infectious Diseases. Oxford University Press
The Journal of infectious diseases, 226(4), 634-643. Oxford University Press
Hoes, J, King, A J, Klooster, T M S V, Berkhof, J, Bogaards, J A & de Melker, H E 2022, ' Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine : Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule ', The Journal of infectious diseases, vol. 226, no. 4, pp. 634-643 . https://doi.org/10.1093/infdis/jiab250, https://doi.org/10.1093/infdis/jiab250
The Journal of infectious diseases, 226(4), 634-643. Oxford University Press
Hoes, J, King, A J, Klooster, T M S V, Berkhof, J, Bogaards, J A & de Melker, H E 2022, ' Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine : Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule ', The Journal of infectious diseases, vol. 226, no. 4, pp. 634-643 . https://doi.org/10.1093/infdis/jiab250, https://doi.org/10.1093/infdis/jiab250
Background In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to preadolescent girls via the National Immunization Program in a 2-dose schedule since 2014. The current study estimates vaccine effectiveness (VE) again
High vaccine effectiveness persists for ten years after HPV16/18 vaccination among young Dutch women
Publikováno v:
Hoes, J, King, A J, Berkhof, J & de Melker, H E 2023, ' High vaccine effectiveness persists for ten years after HPV16/18 vaccination among young Dutch women ', Vaccine, vol. 41, no. 2, pp. 285-289 . https://doi.org/10.1016/j.vaccine.2022.11.057
Vaccine, 41(2), 285-289. Elsevier BV
Vaccine, 41(2), 285-289. Elsevier BV
The current study describes the long-term effectiveness of three-dose HPV16/18 vaccination among Dutch women who were eligible for vaccination during a catch-up campaign and were followed in an observational cohort study. Ten years post vaccination,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e02d51917e8b685971a21aa4a33c6966
http://hdl.handle.net/10029/626301
http://hdl.handle.net/10029/626301
Autor:
Eline S, Wijstma, Vita W, Jongen, Catharina J, Alberts, Hester E, de Melker, Joske, Hoes, Maarten F, Schim van der Loeff
Publikováno v:
Epidemiology (Cambridge, Mass.). 34(1)
Approaches to estimating clearance rates, an important metric of human papillomavirus (HPV) clearance, for HPV groupings differ between studies. We aimed to identify the approaches used in the literature for estimating grouped HPV clearance rates. We
Autor:
Petra J. Woestenberg, Audrey J. King, Johannes Berkhof, Hester E. de Melker, Joske Hoes, Christian J. P. A. Hoebe, Marianne A B van der Sande, Birgit H B van Benthem, Johannes A. Bogaards
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 72(5), E103-E111
Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press
Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770
Clinical Infectious Diseases, 72(5), E103-E111
Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press
Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770
Background Human papillomavirus (HPV) vaccination programs achieve substantial population-level impact, with effects extending beyond protection of vaccinated individuals. We assessed trends in HPV prevalence up to 8 years postvaccination among men a
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:2243-2254
Background: In the Netherlands, bivalent human papillomavirus (HPV) vaccination was included in the National Immunization Program for 12-year-old girls in 2010 (vaccination coverage, 45%–60%). We examined possible changes in HPV seroprevalence in t
Autor:
Mirjam J. Knol, Naomi van Marm-Wattimena, Hester E. de Melker, Hella Pasmans, Robine Donken, Rutger M. Schepp, Audrey J. King, Fiona R. M. van der Klis, Joske Hoes
Publikováno v:
The Journal of infectious diseases, 221(11), 1884-1894. Oxford University Press
Hoes, J, Pasmans, H, Knol, M J, Donken, R, van Marm-Wattimena, N, Schepp, R M, King, A J, van der Klis, F R M & de Melker, H E 2020, ' Persisting Antibody Response 9 Years After Bivalent Human Papillomavirus (HPV) Vaccination in a Cohort of Dutch Women : Immune Response and the Relation to Genital HPV Infections ', The Journal of infectious diseases, vol. 221, no. 11, pp. 1884-1894 . https://doi.org/10.1093/infdis/jiaa007
Journal of Infectious Diseases, 221(11), 1884-1894. OXFORD UNIV PRESS INC
Hoes, J, Pasmans, H, Knol, M J, Donken, R, van Marm-Wattimena, N, Schepp, R M, King, A J, van der Klis, F R M & de Melker, H E 2020, ' Persisting Antibody Response 9 Years After Bivalent Human Papillomavirus (HPV) Vaccination in a Cohort of Dutch Women : Immune Response and the Relation to Genital HPV Infections ', The Journal of infectious diseases, vol. 221, no. 11, pp. 1884-1894 . https://doi.org/10.1093/infdis/jiaa007
Journal of Infectious Diseases, 221(11), 1884-1894. OXFORD UNIV PRESS INC
The bivalent human papillomavirus (HPV) vaccine is highly effective and induces robust serological responses. Using a Dutch prospective cohort initiated in 2009, including 744 vaccinated and 294 unvaccinated girls (1993–1994) who provide a vaginal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4822fb2c3f76c06cb3498469e8d6d4a
https://hdl.handle.net/1887/3181333
https://hdl.handle.net/1887/3181333
Autor:
Petra J. Woestenberg, Joske Hoes, A. J. King, Gina Ogilvie, Chris J.L.M. Meijer, Robine Donken, M.J. Knol, Simon Dobson, Johannes A. Bogaards, H.E. de Melker, Joel Singer
Publikováno v:
Donken, R, Hoes, J, Knol, M J, Ogilvie, G S, Dobson, S, King, A J, Singer, J, Woestenberg, P J, Bogaards, J A, Meijer, C J L M & De Melker, H E 2020, ' Measuring vaccine effectiveness against persistent HPV infections : a comparison of different statistical approaches ', BMC Infectious Diseases, vol. 20, no. 1, 482 . https://doi.org/10.1186/s12879-020-05083-7
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Infectious Diseases, 20(1):482. BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases, 20(1):482. BioMed Central Ltd
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Infectious Diseases, 20(1):482. BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases, 20(1):482. BioMed Central Ltd
Background Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approaches to estimate the vaccine ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6816bbdbbcfa1b51f8984ecc1ec90c
Autor:
Anne-Marie Buisman, F.R.M. van der Klis, H.E. de Melker, M.J. Knol, Joske Hoes, Liesbeth Mollema
Infectious diseases can differ by sex in their incidence, prevalence, or severity of disease. These differences may be induced by sex-dependent immune responses and resulting protection, for example after vaccination. Therefore, this study aims to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eae56ebb582e62841c73a27b20e7a77
http://hdl.handle.net/10029/623353
http://hdl.handle.net/10029/623353